Johnson & Johnson

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: Did Abbott rep in India kill himself over sales goals?

Pharmalot By Ed Silverman

A Johnson & Johnson unit to pay $18 million for causing false claims

Pharmalot By Ed Silverman

Former execs at J&J division convicted of illegally distributing devices

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: Pharma faces challenges as AIDS patients live longer

Pharmalot By Ed Silverman

J&J must pay $70 million to male teen who took Risperdal and developed large breasts

Pharmalot By Ed Silverman

Up and down the ladder: The latest comings and goings

Pharmalot By Ed Silverman

Up and down the ladder: The latest comings and goings

Pharmalot By Ed Silverman

J&J sued by two states, alleging hidden vaginal mesh risks

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: Investors tell pharma to ‘take control’ of the pricing debate

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: J&J ordered to pay $55m in talcum powder trial

Pharmalot By Ed Silverman

More drug makers are taking hefty price hikes on more drugs

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: Pfizer and Allergan call off their merger

Pharmalot By Ed Silverman

Up and down the ladder: The latest comings and goings

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: Drug makers threaten to cut R&D spending in Japan

Pharmalot By Ed Silverman

Drug makers paid fewer fines for bad behavior in recent years

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: Johnson & Johnson to pay $498M over hip implant injuries

Pharmalot By Ed Silverman

Up and down the ladder: The latest comings and goings